Henlius’ Ophthalmic Bevacizumab Program Moves Ahead
IND Approval From US FDA Follows Nod From Australia’s TGA
Shanghai Henlius Biotech is planning to move forward with wet AMD trials for its bevacizumab biosimilar rival to Avastin following a nod from the US FDA.
